Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34016| Title: | Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170. | Austin Authors: | Margalit, Ofer;Harmsen, William S;Shacham-Shmueli, Einat;Voss, Molly M;Boursi, Ben;Wagner, Anna D;Cohen, Romain;Olswold, Curtis L;Saltz, Leonard B;Goldstein, Daniel A;Hurwitz, Herbert;Tebbutt, Niall C ;Kabbinavar, Fairooz F;Adams, Richard A;Chibaudel, Benoist;Grothey, Axel;Yoshino, Takayuki;Zalcberg, John;de Gramont, Aimery;Shi, Qian;Lenz, Heinz-Josef | Affiliation: | Tel-Aviv University, Tel-Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel. Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA. Tel-Aviv University, Tel-Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel. Department of Quantitative Science Research, Mayo Clinic, Scottsdale, AZ, USA. Department of Oncology, Division of Medical Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA; Sorbonne University, INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France. Memorial Sloan Kettering Cancer Centre, New York, NY, USA. Rabin Medical Centre, Petach Tikvah, Israel. Duke Cancer Institute, Duke University, Durham, NC, USA. Austin Health David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA. Cardiff University and Velindre Cancer Centre, Cardiff, UK. Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France. West Cancer Center, Germantown, TN, USA. Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia. Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France. Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA. Department of Gastrointestinal Oncology, Keck School of Medicine at USC, Los Angeles, CA, USA. |
Issue Date: | 28-Sep-2023 | Date: | 2023 | Publication information: | European Journal of Cancer (Oxford, England : 1990) 2023-09-28 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/34016 | DOI: | 10.1016/j.ejca.2023.113339 | ORCID: | Journal: | European Journal of Cancer (Oxford, England : 1990) | Start page: | 113339 | PubMed URL: | 37813779 | ISSN: | 1879-0852 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.